The global market for Biotechnology Instrumentation is estimated at US$51.4 Billion in 2023 and is projected to reach US$74.9 Billion by 2030, growing at a CAGR of 5.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Looking ahead, AI integration and sustainability practices will reshape biotechnology instrumentation, supporting high-throughput screening and expanding point-of-care testing capabilities. Miniaturization allows for flexible use, while AI and machine learning improve data analysis accuracy. With a focus on sustainability and the expansion of point-of-care testing, biotechnology instrumentation continues to evolve, meeting the diverse needs of scientific research and healthcare.
Looking ahead, AI integration and sustainability practices will reshape biotechnology instrumentation, supporting high-throughput screening and expanding point-of-care testing capabilities. Miniaturization allows for flexible use, while AI and machine learning improve data analysis accuracy. With a focus on sustainability and the expansion of point-of-care testing, biotechnology instrumentation continues to evolve, meeting the diverse needs of scientific research and healthcare.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Immunoassay Systems segment, which is expected to reach US$26.1 Billion by 2030 with a CAGR of a 4.5%. The DNA Sequencing Systems segment is also set to grow at 7.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $13.7 Billion in 2023, and China, forecasted to grow at an impressive 5.2% CAGR to reach $11.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Biotechnology Instrumentation Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Biotechnology Instrumentation Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Biotechnology Instrumentation Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abbott Laboratories, Agilent Technologies, Inc., Beckman Coulter Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 147 Featured):
- Abbott Laboratories
- Agilent Technologies, Inc.
- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc.
- Bruker Corporation
- GE HealthCare (UK)
- Gilson Inc.
- Harvard Bioscience Inc.
- Hitachi High-Technologies Corp.
- Illumina Inc.
- Lonza Group AG
- PerkinElmer Inc.
- Roche Diagnostics
- Shimadzu Corp.
- Siemens Healthineers
- Thermo Fischer Scientific Inc.
- Waters Corp.)
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
REST OF WORLD
Companies Mentioned
- Abbott Laboratories
- Agilent Technologies, Inc.
- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc.
- Bruker Corporation
- GE HealthCare (UK)
- Gilson Inc.
- Harvard Bioscience Inc.
- Hitachi High-Technologies Corp.
- Illumina Inc.
- Lonza Group AG
- PerkinElmer Inc.
- Roche Diagnostics
- Shimadzu Corp.
- Siemens Healthineers
- Thermo Fischer Scientific Inc.
- Waters Corp.)
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 246 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 51.4 Billion |
| Forecasted Market Value ( USD | $ 74.9 Billion |
| Compound Annual Growth Rate | 5.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
